Overview
- Editors:
-
-
Benjamin Winograd
-
EORTC New Drug Development Office, Free University Hospital, Amsterdam, The Netherlands
-
Michael Peckham
-
Central Office, British Postgraduate Medical Federation, London, UK
-
Herbert Michael Pinedo
-
Department of Oncology, Free University Hospital, Amsterdam, The Netherlands
Access this book
Other ways to access
Table of contents (36 papers)
-
-
Biological Behaviour of Human Tumours Transplanted in Mice and the Evaluation of Therapeutic Response
-
-
- G. G. Steel, M. J. Peckham
Pages 3-9
-
-
-
Prediction of Tumour Response for the Individual Patient by the Human Tumour Xenograft
-
-
-
Prediction of Antitumour Activity per Tumour Type by the Human Tumour Xenograft
-
-
-
- B. J. M. Braakhuis, G. B. Snow
Pages 37-39
-
-
- J. Mattern, K. Wayss, M. Volm
Pages 47-50
-
- J. Carmichael, J. F. Smyth
Pages 51-55
-
- L. R. Kelland, K. S. Tonkin
Pages 57-62
-
- Ø. Fodstad, S. Aamdal, A. Pihl
Pages 63-67
-
Preclinical Evaluation of Analogs of Known Anticancer Agents
-
-
-
- G. Pezzoni, F. C. Gluliani
Pages 75-78
-
New Drugs
-
-
- B. J. M. Braakhuis, A. Leyva, H. M. Pinedo, G. B. Snow
Pages 81-83
About this book
Starting in 1986, the European School of Oncology has expanded its activities in post graduate teaching, which consisted mainly of traditional disease-orientated courses, by promoting new educational initiatives. One of these is the cloister seminars, short meet ings intended for highly qualified oncologists and dealing with specific, controversial aspects of clinical practice and research. Another is the institution of permanent study groups, also called task forces, where a limited number of leading experts are invited to meet once a year with the aim of defining the state of the art and possibly reaching a consensus on developments and treatment in specific fields of oncology. This series of ESO Monographs was designed with the specific purpose of disseminat ing the results of the most interesting of the seminars and study groups, and providing concise and updated reviews of the subjects discussed. It was decided to keep the layout very simple in order to keep costs to a minimum and make the monographs available in the shortest possible time, thus overcoming a com mon problem in medical literature: that of the material being outdated even before publication. Umberto Veronesi Chairman, Scientific Committee European School of Oncology Position Paper on the Application of Human Tumour Xenografts as a Model for Preclinical Phase" Studies in the Evaluation of New Anticancer Compounds Outcome of a seminar on Human Tumour Xenografts organised by the European School of Oncology, Milan, 26th-27th May, 1986.
Editors and Affiliations
-
EORTC New Drug Development Office, Free University Hospital, Amsterdam, The Netherlands
Benjamin Winograd
-
Central Office, British Postgraduate Medical Federation, London, UK
Michael Peckham
-
Department of Oncology, Free University Hospital, Amsterdam, The Netherlands
Herbert Michael Pinedo